The effects of nutraceuticals in the treatment of non-alcoholic fatty liver disease: an integrative review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/5866 |
Resumo: | Nonalcoholic fatty liver disease (NAFLD) is characterized by fat accumulation in hepatocytes in the absence of alcohol intake and it’s the most common chronic liver disease worldwide. The pillars of NAFLD treatment are healthy lifestyle such as dietary changes, regular physical activity and gradual weight loss. This study aimed to perform an integrative review about the effects of nutraceuticals in the treatment of NAFLD. For the bibliographic survey, papers were searched in PubMed, LILACS and SciELO databases in Portuguese, English and Spanish published in the last 5 years in Portuguese, English and Spanish. The combination of the following descriptors was applied: “Non Alcoholic Fatty Liver Disease”, “Nutraceuticals” and “Diet”. The selected articles point to a relationship of omega-3, resveratrol and curcumin consumption with improvements of some markers related to NAFLD, serving as an alternative therapy in the treatment of NAFLD. Despite the effects related to the use of nutraceuticals in the treatment of NAFLD, there is a need for further research about the subject. |
id |
UNIFEI_f09b412c9dd68b206e0ce37fdf76ec5d |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/5866 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
The effects of nutraceuticals in the treatment of non-alcoholic fatty liver disease: an integrative reviewLos efectos de los nutracéuticos en el tratamiento de la enfermedad del hígado graso no alcohólico: una revisión integradoraOs efeitos dos nutracêuticos no tratamento da doença hepática gordurosa não alcoólica: uma revisão integrativaA doença hepática gordurosa não alcoólica (DHGNA) é caracterizada pelo acúmulo de gordura nos hepatócitos na ausência de ingestão alcoólica e é a mais comum das doenças crônicas do fígado no mundo. Os pilares do tratamento da DHGA sãoestilo de vida sauNonalcoholic fatty liver disease (NAFLD) is characterized by fat accumulation in hepatocytes in the absence of alcohol intake and it’s the most common chronic liver disease worldwide. The pillars of NAFLD treatment are healthy lifestyle such as dietary cEnfermedad del hígado graso no alcohólicoNutracéuticosDieta. Nonalcoholic fatty liver disease (NAFLD) is characterized by fat accumulation in hepatocytes in the absence of alcohol intake and it’s the most common chronic liver disease worldwide. The pillars of NAFLD treatment are healthy lifestyle such as dietary changes, regular physical activity and gradual weight loss. This study aimed to perform an integrative review about the effects of nutraceuticals in the treatment of NAFLD. For the bibliographic survey, papers were searched in PubMed, LILACS and SciELO databases in Portuguese, English and Spanish published in the last 5 years in Portuguese, English and Spanish. The combination of the following descriptors was applied: “Non Alcoholic Fatty Liver Disease”, “Nutraceuticals” and “Diet”. The selected articles point to a relationship of omega-3, resveratrol and curcumin consumption with improvements of some markers related to NAFLD, serving as an alternative therapy in the treatment of NAFLD. Despite the effects related to the use of nutraceuticals in the treatment of NAFLD, there is a need for further research about the subject. La enfermedad del hígado graso no alcohólico (NAFLD) se caracteriza por la acumulación de grasa en los hepatocitos en ausencia de ingesta alcohólica y es la enfermedad hepática crónica más común en el mundo. Los pilares del tratamiento de DHGA son: estilo de vida saludable, como cambios en la dieta, actividad física regular y pérdida gradual de peso. Este trabajo tuvo como objetivo llevar a cabo una revisión integradora sobre los efectos de los nutracéuticos en el tratamiento de la EHGNA. Para la encuesta bibliográfica, se decidió buscar artículos en las bases de datos PubMed (Biblioteca Nacional de Medicina), LILACS (Literatura Latinoamericana en Ciencias de la Salud) y SciELO (Biblioteca Electrónica en Línea Científica), realizadas con humanos y publicado en los últimos 5 años, en portugués, inglés y español. Se aplicó la combinación de los siguientes descriptores: "Enfermedad Del Hígado Graso No Alcohólico", "Nutracéuticos" y "Dieta". Los artículos seleccionados señalan la relación entre el consumo de nutracéuticos y la mejora de algunos marcadores relacionados con NAFLD, que sirve como una terapia alternativa en el tratamiento de NAFLD. A pesar de los efectos informados sobre el uso de nutracéuticos en el tratamiento de NAFLD, existe la necesidad de realizar más investigaciones sobre el tema abordado. A doença hepática gordurosa não alcoólica (DHGNA) é caracterizada pelo acúmulo de gordura nos hepatócitos na ausência de ingestão alcoólica e é a mais comum das doenças crônicas do fígado no mundo. Os pilares do tratamento da DHGA são: estilo de vida saudável, como modificações na dieta, prática de atividade física regular e perda de peso gradual. Este trabalho teve como objetivo realizar uma revisão integrativa sobre os efeitos dos nutracêuticos no tratamento da DHGNA. Para o levantamento bibliográfico, optou-se pela busca de artigos nas bases de dados PubMed (National Library of Medicine), LILACS (Literatura Latino-Americana em Ciências da Saúde) e SciELO (Scientific Eletronic Library Online), realizados com humanos e publicados nos últimos 5 anos, nos idiomas Português, Inglês e Espanhol. Aplicou-se a combinação dos seguintes descritores: “Doença Hepática Gordurosa não Alcoólica”, “Nutracêuticos” e “Dieta”. Os artigos selecionados apontam a relação do consumo dos nutracêuticos com a melhora de alguns marcadores relacionados à DHGNA, servindo como terapia alternativa no tratamento da DHGNA. Apesar dos efeitos relatados acerca do uso de nutracêuticos no tratamento da DHGNA, observa-se a necessidade de mais pesquisas a respeito do assunto abordado.Research, Society and Development2020-07-20info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/586610.33448/rsd-v9i8.5866Research, Society and Development; Vol. 9 No. 8; e598985866Research, Society and Development; Vol. 9 Núm. 8; e598985866Research, Society and Development; v. 9 n. 8; e5989858662525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/5866/5250Copyright (c) 2020 Karla Katherine Gomes Viana, Ariclécio Cunha de Oliveira, Ana Thaís Alves Lima, Sara Idelbrando da Silva Martinho, Danielly Ramalho de Oliveirahttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessOliveira, Ariclécio Cunha deViana, Karla Katherine GomesLima, Ana Thaís AlvesMartinho, Sara Idelbrando da SilvaOliveira, Danielly Ramalho de2020-08-20T18:00:17Zoai:ojs.pkp.sfu.ca:article/5866Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:29:14.516571Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
The effects of nutraceuticals in the treatment of non-alcoholic fatty liver disease: an integrative review Los efectos de los nutracéuticos en el tratamiento de la enfermedad del hígado graso no alcohólico: una revisión integradora Os efeitos dos nutracêuticos no tratamento da doença hepática gordurosa não alcoólica: uma revisão integrativa |
title |
The effects of nutraceuticals in the treatment of non-alcoholic fatty liver disease: an integrative review |
spellingShingle |
The effects of nutraceuticals in the treatment of non-alcoholic fatty liver disease: an integrative review Oliveira, Ariclécio Cunha de A doença hepática gordurosa não alcoólica (DHGNA) é caracterizada pelo acúmulo de gordura nos hepatócitos na ausência de ingestão alcoólica e é a mais comum das doenças crônicas do fígado no mundo. Os pilares do tratamento da DHGA são estilo de vida sau Nonalcoholic fatty liver disease (NAFLD) is characterized by fat accumulation in hepatocytes in the absence of alcohol intake and it’s the most common chronic liver disease worldwide. The pillars of NAFLD treatment are healthy lifestyle such as dietary c Enfermedad del hígado graso no alcohólico Nutracéuticos Dieta. |
title_short |
The effects of nutraceuticals in the treatment of non-alcoholic fatty liver disease: an integrative review |
title_full |
The effects of nutraceuticals in the treatment of non-alcoholic fatty liver disease: an integrative review |
title_fullStr |
The effects of nutraceuticals in the treatment of non-alcoholic fatty liver disease: an integrative review |
title_full_unstemmed |
The effects of nutraceuticals in the treatment of non-alcoholic fatty liver disease: an integrative review |
title_sort |
The effects of nutraceuticals in the treatment of non-alcoholic fatty liver disease: an integrative review |
author |
Oliveira, Ariclécio Cunha de |
author_facet |
Oliveira, Ariclécio Cunha de Viana, Karla Katherine Gomes Lima, Ana Thaís Alves Martinho, Sara Idelbrando da Silva Oliveira, Danielly Ramalho de |
author_role |
author |
author2 |
Viana, Karla Katherine Gomes Lima, Ana Thaís Alves Martinho, Sara Idelbrando da Silva Oliveira, Danielly Ramalho de |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Oliveira, Ariclécio Cunha de Viana, Karla Katherine Gomes Lima, Ana Thaís Alves Martinho, Sara Idelbrando da Silva Oliveira, Danielly Ramalho de |
dc.subject.por.fl_str_mv |
A doença hepática gordurosa não alcoólica (DHGNA) é caracterizada pelo acúmulo de gordura nos hepatócitos na ausência de ingestão alcoólica e é a mais comum das doenças crônicas do fígado no mundo. Os pilares do tratamento da DHGA são estilo de vida sau Nonalcoholic fatty liver disease (NAFLD) is characterized by fat accumulation in hepatocytes in the absence of alcohol intake and it’s the most common chronic liver disease worldwide. The pillars of NAFLD treatment are healthy lifestyle such as dietary c Enfermedad del hígado graso no alcohólico Nutracéuticos Dieta. |
topic |
A doença hepática gordurosa não alcoólica (DHGNA) é caracterizada pelo acúmulo de gordura nos hepatócitos na ausência de ingestão alcoólica e é a mais comum das doenças crônicas do fígado no mundo. Os pilares do tratamento da DHGA são estilo de vida sau Nonalcoholic fatty liver disease (NAFLD) is characterized by fat accumulation in hepatocytes in the absence of alcohol intake and it’s the most common chronic liver disease worldwide. The pillars of NAFLD treatment are healthy lifestyle such as dietary c Enfermedad del hígado graso no alcohólico Nutracéuticos Dieta. |
description |
Nonalcoholic fatty liver disease (NAFLD) is characterized by fat accumulation in hepatocytes in the absence of alcohol intake and it’s the most common chronic liver disease worldwide. The pillars of NAFLD treatment are healthy lifestyle such as dietary changes, regular physical activity and gradual weight loss. This study aimed to perform an integrative review about the effects of nutraceuticals in the treatment of NAFLD. For the bibliographic survey, papers were searched in PubMed, LILACS and SciELO databases in Portuguese, English and Spanish published in the last 5 years in Portuguese, English and Spanish. The combination of the following descriptors was applied: “Non Alcoholic Fatty Liver Disease”, “Nutraceuticals” and “Diet”. The selected articles point to a relationship of omega-3, resveratrol and curcumin consumption with improvements of some markers related to NAFLD, serving as an alternative therapy in the treatment of NAFLD. Despite the effects related to the use of nutraceuticals in the treatment of NAFLD, there is a need for further research about the subject. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-07-20 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/5866 10.33448/rsd-v9i8.5866 |
url |
https://rsdjournal.org/index.php/rsd/article/view/5866 |
identifier_str_mv |
10.33448/rsd-v9i8.5866 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/5866/5250 |
dc.rights.driver.fl_str_mv |
http://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 9 No. 8; e598985866 Research, Society and Development; Vol. 9 Núm. 8; e598985866 Research, Society and Development; v. 9 n. 8; e598985866 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052653847445504 |